Definition of Normotensive Shock
Normotensive shock is a life-threatening state of circulatory failure with evidence of tissue hypoperfusion (elevated lactate, decreased urine output, altered mental status, abnormal skin perfusion) occurring despite a systolic blood pressure ≥90 mmHg and absence of vasopressor support.
Core Concept
The 2025 ESICM guidelines explicitly state that hypotension is commonly present in shock but is NOT required to define shock 1. This critical distinction recognizes that compensatory mechanisms can maintain arterial pressure even when severe tissue hypoperfusion exists. The prognostic significance of lactate appears superior to blood pressure in predicting outcomes 1.
Diagnostic Criteria
Normotensive shock requires the simultaneous presence of:
Blood Pressure Parameters
- Systolic blood pressure ≥90 mmHg
- No vasopressor support required
Evidence of Tissue Hypoperfusion (Multiple Markers Required)
The 2025 ESICM guidelines emphasize a multimodal approach rather than relying on a single variable 1. Look for:
- Lactate elevation (>2.0 mmol/L, with even small increases above this threshold associated with increasing mortality) 1
- Skin perfusion abnormalities: prolonged capillary refill time, mottling, cool extremities 1
- Decreased urine output (oliguria) 1
- Altered mental status 1
Hemodynamic Confirmation (When Available)
Clinical Context and Recognition
Normotensive shock represents a pre-cardiopulmonary failure state where compensatory mechanisms temporarily preserve blood pressure despite inadequate tissue perfusion 4. This phenotype is particularly relevant in:
- Intermediate-risk pulmonary embolism: Studies show 34-37% of these patients are in normotensive shock despite stable blood pressure 3
- Cardiogenic shock: Normotensive and hypotensive cardiogenic shock share similar degrees of cardiac impairment (cardiac indices well below 2.0 L/min/m²) and end-organ dysfunction 5
Critical Pitfalls
The most dangerous pitfall is delayed recognition. Normotensive shock patients demonstrate less predictable deterioration trajectories compared to hypotensive shock—51% show apparent stability before rapid deterioration 5. This "stable" appearance leads to:
- Delayed referrals (median 14 hours longer than hypotensive shock) 5
- Underutilization of advanced therapies
- Missed opportunities for treatment escalation
Do not wait for hypotension to develop before acting. Serial assessment of multiple perfusion markers is essential, as improvements in blood pressure may not translate into improved tissue perfusion 1.
Assessment Strategy
Follow this algorithmic approach:
- Confirm adequate blood pressure (SBP ≥90 mmHg, no vasopressors)
- Assess skin perfusion at bedside: capillary refill time, mottling, temperature 1, 4
- Measure lactate immediately (>2.0 mmol/L is abnormal) 1
- Monitor urine output and mental status 1
- If central access available: measure ScvO₂ and Pv-aCO₂ 1
- Perform serial measurements—single values are insufficient 1
The presence of concordant clinical signs of tissue hypoperfusion despite normal blood pressure defines normotensive shock and should trigger immediate treatment escalation 4.